15th–16th March 2023
13:30-18:30h CET
Epithelioid Sarcoma Digital Expert Panel 2023
Welcome to the second Epithelioid Sarcoma Digital Expert Panel that will take place on March 15-16th 2023. The translational conference will be the continuation of the digital expert meeting that was successfully held in 2021 and will be moderated by Prof. Dr. Dr. Thomas Grünewald, Head of the Division for Translational Pediatric Sarcoma Research at the German Cancer Research Center (DKFZ) and Hopp Children's Cancer Center (KiTZ) Heidelberg, and by Dr. Sandro Pasquali, Clinician Scientist at the Sarcoma Service and the Molecular Pharmacology of Fondazione IRCCS Istituto Nazionale dei Tumori in Milano.
The meeting is meant for experts in sarcoma research, treating clinicians and scientists from related disciplines. It provides a forum for the exchange and discussion of current research aspects including new therapeutic approaches around epithelioid sarcoma. The event promotes networking and discussion among experts and lays the foundation for future international collaborations.
We are looking forward to see you at the panel in March.
Kind regards
Dr. Michael Wortmann Andrea Bolzicco
SMARCB1 e.V. Orchestra per la Vita Aps
Dr. Michael Wortmann, michael.wortmann@smarcb1.de , https://www.smarcb1.de
SMARCB1 e.V. Cancer Research for young people | Forschpfad 6, 51427 Bergisch Gladbach, Germany
Andrea Bolzicco, andrea.bolzicco@orchestraperlavita.org, https://www.orchestraperlavita.org
Orchestra per la vita Aps | Via Canada, 15 – 00060 Formello (Rome), Italy
We thank the new organization “MC4 in corsa per la vita !” ETS (Italy) for supporting the event.
Panel Speaker
Prof. Dr. Dr. Thomas Grünewald
Head of Division for Translational Pediatric Sarcoma Research, the German Cancer Research Center (DKFZ) and Hopp Children's Cancer Center (KiTZ) Heidelberg
Dr. Sandro Pasquali
Clinician Scientist, Sarcoma Service and the Molecular Pharmacology, Fondazione IRCCS Istituto Nazionale dei Tumori in Milano
Prof. Dr. Vincenzo Cerullo
Head of Immunovirotherapy Lab, Division of Pharmaceutical Biosciences, University of Helsinki
Dr. Paul Huang
Molecular and Systems Oncology, Division of Molecular Pathology, Institute of Cancer Research, London
Cigall Kadoch, PhD
Associate Professor of Pedriatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School
Charles Keller, MD
Scientific Director, Children's Cancer Therapy Development Institute
Dr. Noemi Arrighetti, PhD
Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori
PD Dr. med Pascal Johann
Experimental Oncology and Tumor Epigenetics, University Hospital Augsburg
Prof. Alberto Danielli
Associate Professor Molecular Biology, Department of Pharmacy and Biotechnology, University of Bologna
Cristina R. Antonescu, MD
Director, Bone and Soft Tissue Pathology, Memorial Sloan Kettering Cancer Center
Prof. Anna M. Czarnecka
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology in Warsaw
Prof. Maria Rescigno
Deputy Rector with responsibility for research and Group Leader Mucosal immunology and microbiota Unit, Humanitas Research Hospital
Dr. Vittoria Matafora
Staff Scientist at IFOM Proteomics Lab, the FIRC Institute for Molecular Oncology, Milan
Prof. Dario Sangiolo
Associate Professor at the Department of Oncology, University of Turin
Dr. Marco Gambarotti
Head of the structure "Anatomy and pathological histology" - Istituto Ortopedico Rizzoli, Bologna
Dr. Luca Sigalotti
Chief Biologist - Centro di Riferimento Oncologico, Aviano
Sophie Postel-Vinay, MD, PhD, HDR
Physician Scientist, Drug Development Department and U981 INSERM research unit, Gustave Roussy Cancer Campus
Andrea Bolzicco
Associazione Orchestra per la Vita - APS
Dr. Michael Wortmann
SMARCB1 e.V. - Cancer Research for young People
Excerpt presentations
(Agenda in progress)
(Agenda in progress)
Christina Antonescu The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms
Noemi Arrighetti Antitumor activity of tazemetostat and doxorubicin combination: different outcomes in two epithelioid sarcoma models
Anna Czarnecka Long-term results of epithelioid sarcoma multidisciplinary treatment in reference sarcoma center
Vincenzo Cerullo Personalized cancer vaccine for epitheliod sarcoma
Alberto Danielli Nanobiotechnological engineering the M13 phage for targeted photosonodynamic therapy of Epitheliod Sarcoma
Marco Gambarotti RIZZOLI Muscolo-Skeletal tumor BIOBANK
Thomas Grünewald Translational and functional genomics of Epithelioid sarcoma
Paul Huang Proteomic characterisation of SMARCB1-deficient cancers
Pascal Johann Epigenetic vulnerabilities of epithelioid sarcomas - a comperative analysis with other SMARCB1 deficient entities
Cigall Kadoch Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in SMARCB1-Deficient Malignancies
Charles Keller Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biology
Vittoria Matafora Proteomics analysis of epithelioid sarcoma
Sophie Postel-Vinay Exploring tumor heterogeneity in Epithelioid Sarcoma
Maria Rescigno Soft-tissue sarcoma microbiota and immunology
Dario Sangiolo Immunotherapy with CAR redirected cytokine-Induced Killer lymphocytes as explorative approach against Epithelioid Sarcoma
Luca Sigalotti Multi-omics profiling of epithelioid sarcoma unveils biologic differences of proximal and classic variant
Technical information
Digital conference
The Epithelioid Sarcoma Digital Expert Panel is a digital event and will be hostet online. Once you have registered as a participant, you will receive more information and a link via email to dial-in on both days of the event.
Technial Questions
For technical questions please contact us by email: info@smarcb1.de